Bio-Techne (TECH) EBT Margin (2009 - 2026)
Bio-Techne's quarterly EBT Margin came in at 22.87% in Q1 2026, up 1077.0% year-on-year from 1.94% in Q1 2025, and up 33.25% quarter-over-quarter from 17.16% in Q4 2025.
Bio-Techne has reported EBT Margin for 18 years, with the latest figure at 22.87% in Q1 2026.
- For the quarter ending Q1 2026, EBT Margin rose 1077.0% year-over-year to 22.87%; the trailing twelve-month figure through Mar 2026 stood at 4.98% (down 760.0% YoY), and the FY2025 full-year result was 0.96%, down 1413.0% from the prior year.
- EBT Margin for Q1 2026 stood at 22.87%, up from 17.16% in the prior quarter.
- The five-year high for EBT Margin was 5185.8% in Q3 2022, with the low at 34.6% in Q2 2025.
- Average EBT Margin over 5 years is 320.05%, with a median of 17.9% recorded in 2023.
- Year-over-year, EBT Margin surged 515965 bps in 2022 and sank 516790 bps in 2023.
- Tracing TECH's EBT Margin over 5 years: stood at 24.46% in 2022, then plunged by 50 bps to 12.25% in 2023, then increased by 18 bps to 14.43% in 2024, then climbed by 19 bps to 17.16% in 2025, then surged by 33 bps to 22.87% in 2026.
- The last three EBT Margin figures came in at 22.87% (Q1 2026), 17.16% (Q4 2025), and 16.75% (Q3 2025), per Business Quant data.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EBT Margin (Qtr) |
|---|---|---|---|---|---|
| 1 | Quantum Biopharma | 961,148.99 Bn | 961,148.98 Bn | - | - |
| 2 | Alterity Therapeutics | 744,933.29 Bn | 744,933.26 Bn | - | - |
| 3 | Legend Biotech | 2,540.00 Bn | 2,539.71 Bn | 242.10 Mn | -6.40% |
| 4 | Nanobiotix | 2,199.85 Bn | 2,199.78 Bn | - | - |
| 5 | Akari Therapeutics | 1,635.88 Bn | 1,635.88 Bn | - | - |
| 6 | Vertex Pharmaceuticals | 111.32 Bn | 104.07 Bn | 2.59 Bn | 41.95% |
| 7 | Evaxion A | 62.56 Bn | 62.54 Bn | - | - |
| 8 | Regeneron Pharmaceuticals | 62.55 Bn | 53.79 Bn | 3.31 Bn | 23.05% |
| 9 | Alnylam Pharmaceuticals | 39.57 Bn | 36.56 Bn | 959.66 Mn | 18.99% |
| 10 | Bio-Techne | 7.92 Bn | 7.71 Bn | 208.29 Mn | 22.87% |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 22.87% |
| Dec 31, 2025 | 17.16% |
| Sep 30, 2025 | 16.75% |
| Jun 30, 2025 | -34.60% |
| Mar 31, 2025 | 12.11% |
| Dec 31, 2024 | 14.43% |
| Sep 30, 2024 | 13.88% |
| Jun 30, 2024 | 10.05% |
| Mar 31, 2024 | 20.13% |
| Dec 31, 2023 | 12.25% |
| Sep 30, 2023 | 17.90% |
| Jun 30, 2023 | 29.31% |
| Mar 31, 2023 | 27.26% |
| Dec 31, 2022 | 24.46% |
| Sep 30, 2022 | 5,185.80% |
| Jun 30, 2022 | 27.43% |
| Mar 31, 2022 | 23.68% |
| Dec 31, 2021 | 32.00% |
| Sep 30, 2021 | 26.15% |
| Jun 30, 2021 | -17.53% |
| Mar 31, 2021 | 18.62% |
| Dec 31, 2020 | 25.14% |
| Sep 30, 2020 | 19.27% |
| Jun 30, 2020 | 34.99% |
| Mar 31, 2020 | 24.05% |
| Dec 31, 2019 | 81.29% |
| Sep 30, 2019 | 9.72% |
| Jun 30, 2019 | 11.89% |
| Mar 31, 2019 | 26.98% |
| Dec 31, 2018 | 12.47% |
| Sep 30, 2018 | 10.79% |
| Jun 30, 2018 | -14.03% |
| Mar 31, 2018 | 15.24% |
| Dec 31, 2017 | 14.10% |
| Sep 30, 2017 | 15.88% |
| Jun 30, 2017 | 24.17% |
| Mar 31, 2017 | 21.62% |
| Dec 31, 2016 | 11.52% |
| Sep 30, 2016 | 21.28% |
| Jun 30, 2016 | 7.75% |
| Mar 31, 2016 | 32.44% |
| Dec 31, 2015 | 29.26% |
| Sep 30, 2015 | 28.34% |
| Jun 30, 2015 | 4.97% |
| Mar 31, 2015 | 33.95% |
| Dec 31, 2014 | 38.02% |
| Sep 30, 2014 | 31.89% |
| Jun 30, 2014 | -95.36% |
| Mar 31, 2014 | 48.21% |
| Dec 31, 2013 | 43.11% |
| Sep 30, 2013 | 46.29% |
| Jun 30, 2013 | 51.29% |
| Mar 31, 2013 | 54.90% |
| Dec 31, 2012 | 49.87% |
| Sep 30, 2012 | 50.63% |
| Jun 30, 2012 | 51.62% |
| Mar 31, 2012 | 51.67% |
| Dec 31, 2011 | 50.73% |
| Sep 30, 2011 | 52.19% |
| Jun 30, 2011 | -112.91% |
| Mar 31, 2011 | 59.50% |
| Dec 31, 2010 | 55.64% |
| Sep 30, 2010 | 57.33% |
| Jun 30, 2010 | -129.30% |
| Mar 31, 2010 | 58.96% |
| Dec 31, 2009 | 56.01% |
| Sep 30, 2009 | 59.68% |